Avantor - AVTR Stock Forecast, Price & News

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Avantor Trading Down 1.7 %

Shares of AVTR traded down $0.48 during trading hours on Tuesday, hitting $27.86. The stock had a trading volume of 5,177,452 shares, compared to its average volume of 5,116,820. The company's fifty day simple moving average is $30.54 and its 200 day simple moving average is $32.31. The company has a debt-to-equity ratio of 1.41, a quick ratio of 1.05 and a current ratio of 1.64. Avantor has a 12-month low of $27.50 and a 12-month high of $44.37. The firm has a market cap of $18.78 billion, a P/E ratio of 29.96, a P/E/G ratio of 0.71 and a beta of 1.30.

Avantor (NYSE:AVTR - Get Rating) last released its quarterly earnings data on Thursday, July 28th. The company reported $0.37 EPS for the quarter, missing the consensus estimate of $0.38 by ($0.01). Avantor had a net margin of 8.27% and a return on equity of 27.14%. The company had revenue of $1.91 billion during the quarter, compared to analysts' expectations of $1.98 billion. During the same period last year, the business earned $0.35 earnings per share. The company's revenue for the quarter was up 2.7% compared to the same quarter last year. Equities research analysts forecast that Avantor will post 1.45 EPS for the current fiscal year.

Wall Street Analyst Weigh In

AVTR has been the topic of a number of analyst reports. Barclays lowered their target price on Avantor to $33.00 in a report on Tuesday. Wells Fargo & Company decreased their price objective on Avantor from $42.00 to $33.00 and set an "overweight" rating on the stock in a report on Monday, April 25th. Morgan Stanley decreased their price objective on Avantor from $40.00 to $37.00 and set an "overweight" rating on the stock in a report on Monday, August 1st. Cowen decreased their price objective on Avantor to $39.00 in a report on Tuesday. Finally, The Goldman Sachs Group decreased their price objective on Avantor from $42.00 to $37.00 and set a "buy" rating on the stock in a report on Thursday, July 14th. One research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $39.00.

Insider Buying and Selling at Avantor

In other news, EVP Frederic Vanderhaegen sold 39,000 shares of Avantor stock in a transaction dated Monday, May 23rd. The stock was sold at an average price of $31.61, for a total transaction of $1,232,790.00. Following the sale, the executive vice president now directly owns 126,764 shares of the company's stock, valued at $4,007,010.04. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In related news, EVP Gerard Brophy sold 19,603 shares of Avantor stock in a transaction dated Friday, May 20th. The stock was sold at an average price of $31.27, for a total value of $612,985.81. Following the completion of the transaction, the executive vice president now directly owns 96,935 shares in the company, valued at $3,031,157.45. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Frederic Vanderhaegen sold 39,000 shares of Avantor stock in a transaction dated Monday, May 23rd. The stock was sold at an average price of $31.61, for a total value of $1,232,790.00. Following the completion of the transaction, the executive vice president now owns 126,764 shares of the company's stock, valued at $4,007,010.04. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.